Hong Wang

40.8k citations
749 papers · 25.2k indexed · 5 hit papers · h-index 80

Impact in

  • Oncology top 0.2%
    • Cutaneous Melanoma Detection and Management
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • MicroRNA in disease regulation

Papers in

    • MicroRNA in disease regulation 28
    • Cancer Immunotherapy and Biomarkers 38
    • Cancer Cells and Metastasis 24

Hong Wang

710 papers receiving 24.7k citations

Hit Papers

TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients 2015 · 608 citations
6082005202620122019250500750

Peers

Hong Wang
Comparison fields: 5 of 192
  • Oncology 6.9k
  • Cancer Research 3.1k
  • Immunology 4.1k
  • Molecular Biology 9.9k
  • Pathology and Forensic Medicine 2.0k
Replace Stephen J. Chanock with:
Stephen J. Chanock United States
Adriana Albini Italy
Jianfeng Xu United States
Gerry Melino Italy
Lin Zhang China
Ryozo Nagai Japan
Towia A. Libermann United States
Boris Zhivotovsky Sweden
Michael S. Pepper South Africa
James A. McCubrey United States
Hong Wang relative to Stephen J. Chanock United States Stephen J. Chanock's profile →
Citations per field
00.5×1.5×1.9×
Stephen J. Chanock · 1×
Citations per year

Countries citing papers authored by Hong Wang

Since Specialization
Citations

This map shows the geographic impact of Hong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Wang more than expected).

Fields of papers citing papers by Hong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Wang. The network helps show where Hong Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Hong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hong Wang Line = papers co-authored together Hong Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20250
3 20244
4 202410
5 20245
6 20241
7 202212
8
Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
20207
9
Major Hepatectomy in Elderly Patients with Large Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
20201
10 201915
11 201785
12 201758
13 201526
14 2013175
15 201368
16 201279
17 201126
18 2008117
19 200525
20 1999436

About Hong Wang

Hong Wang is a scholar working on Cancer Research, Oncology, Hematology, Immunology and Genetics, having authored 749 papers that have together received 25.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (38 papers), Immunotherapy and Immune Responses (31 papers), Effects of Radiation Exposure (29 papers), MicroRNA in disease regulation (28 papers), Hematopoietic Stem Cell Transplantation (26 papers), Mesenchymal stem cell research (25 papers), Cancer Cells and Metastasis (24 papers) and Immune Cell Function and Interaction (23 papers). The work is most often cited by research in Oncology (6.9k citations), Cancer Research (3.1k citations), Immunology (4.1k citations), Molecular Biology (9.9k citations) and Pathology and Forensic Medicine (2.0k citations). Hong Wang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Robert M. Elashoff, Donald L. Morton, Scott M. Eisenkop, Richard L. Friedman, Samir Hanash, Dave S.�B. Hoon, Joel S. Greenberger, Michael W. Epperly, Richard Essner and John M. Kirkwood. Their work appears in journals such as Journal of Clinical Oncology, Radiation Research, Cancer Research, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026